Back Home Search

HR+/HER2 neg

    • Protocols
    • UW19046

      OPEN TO ACCRUAL

      WONIX - Pilot Study of FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

    • UW23076

      OPEN TO ACCRUAL

      Biomarkers to Detect Endocrine Therapy Resistance in Lobular Breast Cancer

    • UW24055

      OPEN TO ACCRUAL

      P3 Study of MK-2870 and Combo with Pembro, verses Tx of Choice in Pts with HR+, HER2 Adv or Met BC

    • UW25096

      OPEN TO ACCRUAL

      P3 Study of Efficacy and Safety of RLY-2608 + Fulvestrant Vs Capivasertib + Fulvestrant as Tx in BC